Search

everythinglearnresearchcommunity

for

Search:↓

Hormone levels in hair vary across the head, with the highest concentration of a key hormone linked to hair loss at the top.

The study created a new method to test drugs that affect hormone processing in skin.

Sex hormones affect brain cells differently in males and females.

Moxibustion may help improve ovarian function by changing androgen levels.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Red light at 8 mW/cm2 most effectively promotes hair cell growth and affects key growth pathways, especially in cells treated with a hair loss-related hormone.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Moringa seed oil may help prevent hair loss and promote hair growth.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Compound 4 is a promising treatment for hair loss with low toxicity.

Finasteride improves hair growth in men with androgenetic alopecia.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

A new gene, JMJD1C, may affect testosterone levels in men.

Botulinum toxin treatment improves hair follicle width and length in androgenetic alopecia.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.